MEN2A is mainly caused by activating mutations in exons 10 and 11, and is characterized by variable risks of aggressive MTC, pheochromocytoma, PHPT or cutaneous lichen amyloid depending on the mutation (14). This evidence concerns the gene RET and hereditary pheochromocytoma-paraganglioma.